Nucleolar Arf sequesters Mdm2 and activates p53

Nature Cell Biology

Volumn 1, Issue 1, 1999, Pages 20-26

  Weber, Jason D ^a   Taylor, Laura J ^b   Roussel, Martine F ^a   Sherr, Charles J ^a   Bar Sagi, Dafna ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; MDM2 PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; PROTEIN MDM2; PROTEIN P53; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; CELL AGING; CELL STRAIN 3T3; CYTOLOGY; FEEDBACK SYSTEM; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; NUCLEOLUS; ONCOGENE MYC; PHYSIOLOGY; TUMOR SUPPRESSOR GENE; ULTRASTRUCTURE;

3T3 CELLS; ADP-RIBOSYLATION FACTORS; ANIMALS; CELL AGING; CELL NUCLEOLUS; FEEDBACK; FIBROBLASTS; GENE EXPRESSION REGULATION; GENES, MYC; GENES, P53; MICE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033130010     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/8991     Document Type: Article

References (39)

1. Quelle, D. E., Zindy, F., Ashmun, R. A. & Sherr, C. J. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83, 993-1000 (1995).
2. Serrano, M., Hannon, G. J. & Beach, D. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4. Nature 366, 704-707 (1993).
3. ARF. Cell 91, 649-659 (1997).
4. Zindy, F. et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12, 2424-2433 (1998).
5. ARF tumor suppressor. Genes Dev. 12, 2434-2442 (1998).
6. ARF links pRB and p53. Nature 395, 124-125 (1998).
7. ARF links the tumour suppressor p53 to Ras. Nature 395, 125-126 (1998).
8. ARF induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation. Proc. Natl Acad. Sci. USA 95, 13194-13199 (1998).
9. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983 (1998).
10. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev. 12, 2984-2991 (1998).
11. Prives, C. Signaling to p53: breaking the MDM2-p53 circuit. Cell 95, 5-8 (1998).
12. Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37 (1996).
13. Alcorta, D. A. et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Prof. Natl Acad. Sci. USA 93, 13742-13747 (1996).
14. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol. 16, 859-867 (1996).
15. INK4a. Cell 88, 593-602 (1997).
16. INK4a tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene 15, 203-211 (1997).
17. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713-723 (1998).
18. Zhang, Y., Xiong, Y. & Yarbrough, W. G. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways. Cell 92, 725-734 (1998).
19. Kamijo, T. et al. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292-8297 (1998).
20. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5014 (1998).
21. Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245 (1992).
22. Oliner, J. D. et al. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860 (1993).
23. Roth, J., Dobbelstein, M., Freedman, D., Shenk, T. & Levine, A. J. Nucleocytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17, 554-564 (1998).
24. Freedman, D. A. & Levine, A. J. Nuclear export is required for degradation of endogenous p53 by mdm2 and human papillomavirus E6. Mol Cell. Biol. 18, 7288-7293 (1998).
25. Honda, R., Tanaka, H. & Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27 (1997).
26. ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J. 18, 22-27 (1999).
27. ARF. Proc. Natl Acad. Sci. USA 94, 3436-3440 (1997).
28. Scheer, U., Thiry, M. & Goessens, G. Structure, function, and assembly of the nucleolus. Trends Cell Biol. 3, 236-241 (1993).
29. Fomproix, N., Gebrane-Younes, J. & Hernandez-Verdun, D. Effects of anti-fibrillarin antibodies on building of functional nucleoli at the end of mitosis. J. Cell Sci. 111, 359-372 (1998).
30. Montes de Oca Luna, R., Wagner, D. S. & Lozano, G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203-206 (1995).
31. Jones, S. N., Roe, A. E., Donehower, L. A. & Bradley, A. Rescue of embryonic lethality in Mdm-2-deficient mice by absence of p53. Nature 378, 206-208 (1995).
32. Haupt, V., Maya, R., Kazaz, A. & Oren, M. Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299 (1997).
33. Kuhbutat, M. H., Jones, S. N. & Vousden, K. H. Regulation of p53 stability by Mdm2. Nature 387, 299-303 (1997).
34. Shieh, S.-Y., Ikeda, M., Taya, Y. & Prives, C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334 (1997).
35. Siliciano, J. D. et al. Damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471-3481 (1997).
36. Littlewood, T. D., Hancock, D. C., Danielian, M. G., Parker, M. G., & Evan, G. I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23, 1686-1690 (1995).
37. McCarthy, S. A., Aziz, N. & McMahon, M. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER. Methods Mol. Biol. 85, 137-151 (1997).
38. Ochs, R. L., Lischwe, M. A., Spohn, W. H., & Busch, H. Nucleologenesis: composition and fate of prenucleolar bodies. Biol. Cell 54, 123-134 (1985).
39. Chen, C. & Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752 (1987).